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All cells regulate their contractility by the interaction of actin and myosin. In non-muscle 
cells, however, this interaction is regulated by rho, a GTPase, which is the upstream 
effector for multiple pathways. Cell contractility increases when rho is active, and prior 
research has shown the depolymerization of microtubules (MTs) activates rho. 
Microtubules play a role in many cellular functions and it is thought that either 
associations with MT-associated proteins and/or post-translational modifications to 
tubulin regulate MT functions.  Numerous post-translational modifications (PTMs) to 
microtubules have been identified, but their roles are not well understood. A possible 
relationship between changes in cell contractility and two tubulin post-translational 
modifications, acetylation and detyrosination, has been suggested by past research. We 
investigated if altered cell contractility caused changes in MT acetylation and 
detyrosination. We found that inhibition of rho caused a decrease in the amount of 
acetylation while activation of rho caused an increase. Since MT acetylation and 
detyrosination correlate with more stable MTs, our results suggest that a signaling 
pathway or feedback mechanisms exists in cells that allow them to respond to changes 
in contractility by altering MT dynamics. This not only sheds light on the crosstalk 
between actin and microtubules due to rho having a feedback mechanism as opposed to 
linear, but also allows for the speculation that one of the downstream effects of rho is the 
regulation of the enzymes that control MT acetylation.  
 
 
 
Introduction: 
 The cytoskeleton of the cell is required for cells to alter their shape and size, to 
move and migrate, to interact within and outside of the cell, and to establish polarity. The 
cytoskeleton is also necessary for cell contractility, which is generated by the interaction 
of actin and myosin. Actin filaments are a main component of the cytoskeleton that are 
especially important in cell adhesion, movement, and migration. The myosin family, 
composed of actin-dependent motor proteins, interact with actin filaments and harness 
the power of ATP hydrolysis to cause cell movement. In non-muscle cells, the interaction 
between actin and myosin is regulated by phosphorylation of the myosin light chains, 
which is in turn influenced by a g-protein called rho (Alberts et al., 2009). 
The Rho family of GTPases controls the organization and arrangement of the 
actin cytoskeleton, and includes many proteins including rac, rho, and cdc42. This Rho 
family of GTPases is able to be regularly studied due to the conservation of these 
proteins in organisms throughout evolution (Rajas et al., 2015). GTPases act as 
molecular switches by becoming active when bound to GTP and inactive when the GTP 
is hydrolyzed to GDP. One of these family members, rho, controls and modulates cell 
contractility and adhesion plaque formation through its many downstream effectors. One 
of the rho pathways promotes cell contractility (reviewed by Riching and Keely, 2015). In 
this pathway, when rho becomes active once bound to GTP, a downstream effector 
ROCK, or rho kinase, becomes activated. When active, ROCK has been found to both 
phosphorylate and activate myosin light chains and to phosphorylate, and therefore 
inhibit the myosin light chain phosphatase, and therefore keep the myosin light chains 
active (Figure 1). When phosphorylated, the myosin light chains allow the entire myosin 
motor protein to complete cycle movements along the actin filament, allowing for cellular 
contractility. When bound together, this association of actin filaments, myosin, and other 
proteins form actin stress fibers that stretch across the entirety of the cell to adhesion 
plaques, which are sites in the membrane of a cell that contain proteins that function to 
keep the cell adhesive to the extracellular matrix or other surfaces. Furthermore, it is 
known that when rho is inhibited actin stress fibers and adhesion plaques disassemble 
(Alberts et al., 2009). 
Figure 1: Diagram of the actin-myosin contractility rho pathway 
Another component of the cell’s cytoskeleton, microtubules (MTs), contribute to 
this pathway. Microtubules play roles in various cell functions including chromosome 
segregation, establishment of polarity, vesicle transport, and creating permanent 
structures to create cilia and flagella. MTs are hollow tubes formed by polymers 
composed of the two subunits, alpha-tubulin and beta-tubulin, and have a unique 
characteristic known as dynamic instability. Dynamic instability allows for MTs to 
abruptly switch from polymerizing (lengthening) to depolymerizing (shortening) or 
neither, a state where the MT is considered stable (Figure 2). These changes can occur 
to multiple or individual MTs at any given time and contribute to cell contractility in doing 
so (Alberts et al., 2009). When more microtubules are stabilized, the microtubules 
throughout the entire cell are considered less dynamic. Microtubules have also been 
shown to play a role in the regulation of actin functions by crosstalk between the two 
components of the cytoskeleton. (Alberts et al., 2009).  
Figure 2: Diagram of microtubule dynamic instrability (Reviewed by Cheeseman, IM, and Desai, A. 
“Molecular architecture of thje kinetochore-microtubule interface” Nat Rev Mol Cell Biol. 9 (1):33-46. 2008) 
The concept of dynamic instability with MTs is not entirely understood and it is 
widely thought that post-translational modifications (PTMs) to MTs play a significant role. 
Two of the more studied microtubule PTMs are acetylation and detyrosination, and 
detyrosination has been found to be correlated with MT stability (reviewed by 
Westermann and Weber, 2003). Detyrosination is the removal of the C-terminal amino 
acid tyrosine from an alpha-tubulin dimer via a carboxypeptidase enzyme and it only 
occurs on polymerized MTs, for upon depolymerization the dimers are re-tyrosinated 
(Gundersen et al., 1987). Detyrosination has been found to be a marker in determining 
the length of time a MT has remained polymerized, or stable, rather than occurring to 
stabilize a MT (reviewed by Westermann and Weber, 2003). Acetylation is the addition 
of an acetyl group to a lysine amino acid on the alpha-tubulin on the inside face of the 
microtubule (Figure 3). Histone deacetylase 6 (HDAC6) and SIRT2 have been identified 
as the two deacetylating enzymes, while alpha-TAT1 is the acetylase (reviewed by 
Janke and Bulinski, 2011).  
 
Figure 3: Diagram of microtubule post-translational modifications (Reviewed by Janke and Bulinski, 2012)
Previously in the Danowski Lab, microtubules in C3H10T½ mouse embryo 
fibroblasts subjected to stress by ATP depletion have been observed to become stable, 
as determined by the inability of nocodazole to depolymerize the MTs. MTstability was 
correlated with an increased amount of detyrosinated tubulin and acetylated tubulin. 
Recently, other stresses, including amino acid starvation and UVC radiation, were 
shown to increase the amount of MT acetylation and detyrsoination, compared to control 
cells (Mackeh et al., 2014). Furthermore, it has also been observed that increased MT 
deacetylation due to the activation of histone deacetylase 6 (HDAC6), microtubules are 
found to promote more rapid depolymerization. This suggests that acetylation to 
microtubules decreases microtubule dynamics and plays a role in keeping them 
polymerized (Nam et al., 2010). 
It is known that microtubules influence the contractility of the actin cytoskeleton. 
For example, when microtubule depolymerization was induced by drugs such as 
nocodazole, vinblastine, or colcemid, non-muscle cells responded by forming stress 
fibers and focal adhesions (Danowski, 1989). This observation led to the idea of 
crosstalk between the two components of the cellular cytoskeleton in a mechanistic way 
to balance the compressive and tensile forces within the cell (Danowski, 1989). 
Danowski (1989) also suggested the possibility that MTs sequester a contractility-
stimulation factor, that is released upon MT depolymerization. It was subsequently 
shown that rho activation initiated the pathway to induce cell contractility, while 
microtubule depolymerization has also been seen to induce increased cell contractility, 
so the relationship was investigated and it was observed that the depolymerization of 
microtubules does in fact activate rho (Liu et al., 1997). Chang and colleagues (2008) 
showed that upon depolymerization, MTs release GEF-H1, a microtubule associated 
guanine nucleotide exchange factor known to activate rho. If the depolymerization of 
MTs activates rho, and increases cell contractility, it is possible that the inhibition of cell 
contractility would cause a feedback mechanism to alter the microtubules in some way., 
possibly through MT post-translational modifications. We sought to investigate whether 
evidence of such a feedback mechanism exists by examining the effects to microtubules 
upon altering the rho pathway.  
Another example of intersection between microtubules and cell contractility 
involves the regulation of HDAC6 by tubulin polymerizing protein 1 (TPPP1). Schofield et 
al. (2012) found that TPPP1 binds to HDAC6, and this binding prevents HDAC6 activity. 
However, when TPPP1 is phosphorylated, HDAC6 is released and causes a decrease in 
MT acetylation. The kinase responsible for phosphorylating TPPP1 is ROCK, one of the 
downstream effectors of rho. Thus, they concluded that activation of the rho signaling 
pathway can lead to alterations in MT acetylation, mediated through TPPP1 (Schofield et 
al. 2015). mDia2 has been discovered to cause changes to microtubule detyrosination. 
mDia1 and mDia2 are two diaphanous-related formins that are involved in the capping 
(stabilizing) and the capture (depolymerizing) of microtubules. mDia2 was found to be 
another downstream effector of rho, and when activated separately mDia2 caused an 
increase in the amount of detyrosinated, and therefore assumed stable, microtubules 
(Palazzo et al., 2001). We therefore hypothesized that if rho was inhibited, a significant 
decrease to the amount of detyrosinated microtubules would be observed. 
Due to this research we hypothesized that there was some form of feedback 
mechanism in this cell contractility to microtubules that could be observed through 
looking at post-translational modifications to microtubules. To investigate this, C3H10T½ 
mouse embryonic fibroblast cells will be used to observe the relationships of actin and 
microtubules as well as microtubules and cell contractility. This rho pathway will be 
studied through using a membrane permeant rho inhibitor, ROCK inhibitor, and rho 
activator and examined using immunofluorescence microscopy and western blotting. In 
using antibodies to stain for alpha tubulin, acetylated tubulin, and detyrosinated tubulin, 
the localization, amount, and concentration of both microtubules and the post 
translational modifications can be analyzed. The results could shed further light on the 
mechanisms of microtubule-actin cytoskeletal crosstalk, provide more insight into the 
role of acetylated and detyrosinated microtubules, and explore potential unknown 
downstream pathways of rho.  
 
 
 
 
 
 
 
 
 
Methods: 
Immunofluorescence Microscopy: 
C3H10T½ mouse embryo fibroblasts were grown in a twelve well dish on small cover 
slips to minimize the volume of medium used. Besides the control cells, cells were 
treated with the following membrane permeant treatments: 10uM rho inhibitor, 10 uM 
ROCK inhibitor, and 20 uM rho activator (all from Cytoskeleton, Inc.). The rho inhibitor 
was used in a time course for one, four, and twelve hours, and then in multiple 
experiments for one and four hours. Cells were treated with ROCK inhibitor for one hour 
and the rho activator for two hours. Cells were then fixed in 99% pure ice cold methanol 
for ten minutes. Coverslips were then air dried for five minutes, followed by five washes 
in calcium and magnesium free phosphate buffered saline (CMF-PBS). Coverslips were 
then incubated with a primary antibody for either two hours at 37°C in a moist chamber 
or three hours at room temperature (mouse anti-acetylated tubulin, 1:200; anti-rabbit 
detyrosinated tubulin, 1:150; mouse DM1A for alpha-tubulin, 1:100, aka DM1A). After 
repeating fives washes in PBS, coverslips were incubated in secondary antibody for 
either two hours at 37°C in a moist chamber three hours at room temperature (goat anti-
mouse Alexa Red 1:300; goat anti-mouse Alexa Green 1:300). For acetylated tubulin, 
another wash of five times in PBS was done. Then mouse FITC-DM1A anti-total alpha-
tubulin at 1:100 was added to the coverslips and was incubated in a moist chamber for 
either two hours at 37°C er or three hours at room temperature. After all incubations 
were complete, the coverslips were washed four times in PBS and a fifth time in Milli-Q 
water. The coverslips were then mounted on slides with ProLong Gold Anti Fade w/ 
DAPI stain. Note: all of the antibody dilutions were done with PBS. 
 
 
 
Preparation of Total Cell Lysate: 
C3H10T½ mouse embryo fibroblasts were grown in 60mm sized plates until fully dense. 
Besides a control plate with no drugs added, the plates were treated with either a 10uM 
rho inhibitor for one hour, a 10 uM ROCK inhibitor for one hour, or 20 uM rho activator 
for two hours. Cell lysates were made from these dishes. To do so, the dishes were 
rinsed with warm PBS twice prior to the addition of ice cold RIPA buffer (200 ul) and 
protease inhibitor cocktail (PIC) (1 ul PIC/100ml RIPA buffer). The cells were scraped off 
the plate while keeping it on ice and the liquid containing the cells was transferred to a 
pre-chilled 1.5 ml microfuge tube. While at 4°C, the tubes were mixed for 15 minutes and 
then spun at 12,000 for 5 minutes. After 10ul of each tube was taken to measure the 
protein concentration via nanodrop, the remaining supernatant was transferred to 
another pre-chilled tube and an equal amount of 2x sample buffer with DTTP was 
added. The pellet from the original tube was then disregarded. The lysates were then 
boiled for 6 minutes prior to storage at -20°C. The lysates were thawed when needed for 
use. 
 
Western Blot: 
Pre-cast ten-well Mini-Protean BioRad® 4-15% gels were used for acetylated tubulin 
and total tubulin, lower molecular weight proteins. BioRad® Dual Precision Plus was 
loaded into a well next to the cell lysates. Gel electrophoresis was run at room 
temperature for approximately 45 minutes (90V until the samples left the wells and then 
upped to 150V) in running buffer (3 g TRIS base, 14.4 g glycine, pH 7). At the end of 
electrophoresis a PVDF membrane was rinsed in room temperature 99% methanol and 
washed in transfer buffer for ten minutes. The gel from electrophoresis was also washed 
in transfer buffer for ten minutes (100ml 10X Running Buffer, 1ml 10% SDS/1 liter; 20% 
methanol/1 liter). Once the washes were done, the proteins from the gel were 
transferred onto the PVDF membrane using a semi-dry blotter. Two thick pieces of 
blotting paper were cut to sandwich in the gel and membrane and also soaked in 
transfer buffer (100ml 10X Running Buffer, 1ml 10% SDS/1 liter; 20% methanol/1 liter). 
The gel was placed closer to the cathode and the membrane to the anode, and placed in 
the semi-dry blotter. This was run at 15V for 20 minutes. After the transfer was complete 
the PVDF membrane was washed in blocking buffer for four hours (1 part powdered 
milk/20 parts TTBS). The membrane was then washed 5 times at 4 minutes each in 
TTBS (TrisBuffered Saline (BioRad) + 0.05% Triton X-100) while rocking. The 
membrane was then incubated with the primary antibodies overnight at  4°C (anti-
acetylated tubulin made in mouse 1:2,500; anti-alpha tubulin made in mouse 1:5,000; 
and anti-GAPDH made in mouse 1:3,000) in 10ml TTBS (TrisBuffered Saline (BioRad) + 
0.05% Triton). The next morning the membrane was washed 5 times at 4 minutes each 
in TTBS. After the washes, the PVDF membrane was incubated in secondary antibodies 
for two hours at room temperature (1:10,000 goat anti-mouse HRP) and then subjected 
to one last round of 5 washes at 4 minutes each. Then the PVDF membrane was 
developed with Femto Developing Solution by Piercenet ®. The western blots were 
quantified by the BioRad ® Image Lab. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results: 
Rho Inhibitor disrupts actin stress fibers in mouse embryonic fibrobasts 
 In C3H10T½ mouse fibroblast cells, the membrane permeant rho inhibitor was 
successfully able to disrupt the actin stress fibers in the treated cells compared to the 
control cells. After one hour of treatment with the rho inhibitor, a significant decrease in 
the amount of stress fibers and thickness of the stress fibers was observed in the 
majority of the cells through immunofluorescence microscopy. After four hours the most 
significant disruption of actin stress fibers was seen, along with the delocalization of 
paxillin, a adhesion plaque protein found at the termini of stress fibers (Figure 4). 
Although these changes did not occur to every cell, they were observed in the majority of 
the cells treated with the rho inhibitor compared to the control cells. 
 
Does the inhibition of rho cause any change to the localization or amount of acetylated 
microtubules? 
 C3H10T½ fibroblast cells were subjected to either one hour, four hours, or no 
treatment with the membrane permeant rho inhibitor. The amount of acetylated 
microtubules in control cells varied considerably. In order to detect changes induced rho 
inhibition, cells stained with anti-acetylated tubulin antibody were evaluated visually and 
categorized as having less/decreased, moderate, or more/increased amounts of 
acetylation to microtubules (Figure 5). This categorization was applied to those cells 
treated with the rho inhibitor for one hour and four hours and after three experiments the 
data was quantified. After one and four hours of rho inhibition, there was a decrease in 
the acetylated MTs, as seen by the relative increase in the number of cells categorized 
as having lesser amounts of acetylated MTs. The differences in the number of cells in 
the lesser amounts of acetylated MTs between the control cells and those treated with 
rho inhibitor for one hour, and the control cells and those treated with the rho inhibitor for 
four hours were significant (P=0.002 and P=0.003, respectively). Therefore, it was 
determined that the inhibition of rho significantly decreases the amount of acetylation to 
microtubules. 
 
Does the inhibition of rho cause any change to the localization or amount of 
detyrosinated microtubules?  
A similar analysis was performed to investigate any changes in microtubule 
detyrosination in response to rho inhibition. Although there was a slight increase in the 
number of cells showing moderate amounts of MT detyrosination, the differences were 
not significant (Figure 6). Therefore, it was determined that the inhibition of rho did not 
have any effect on the localization or amount of detyrosination. 
 
Can changes in acetylated tubulin in response to altering rho activity be detected by 
western blotting? 
 The western blot done shows the lysates of control C3H10T½ cells, those treated 
with the rho inhibitor for one hour, ROCK inhibitor for one hour,  and rho activator for two 
hours (Figure 7). Lysates of cells treated with the rho inhibitor for one hour contained 
less acetylated tubulin compared to the control cells. The control protein band, GAPDH, 
was not of equal concentration, so the BioRad Imaging Program was used to ratio the 
amount of GAPDH to acetylated tubulin. It was found that rho inhibition reduced the 
amount of acetylated tubulin by 40%, but surprisingly ROCK inhibition had no effect. 
Activation of rho increased tubulin acetylation by 100% (Table 1).  analyze and compare 
the concentrations of the GAPDH to Acetylated Tubulin. The ratios given showed that 
while the cells treated with the ROCK inhibitor had no difference compared to the 
control, the cells treated with the rho inhibitor had less acetylated tubulin than the control 
and the cells treated with the rho activator had more acetylated tubulin (Table 1).  
 
Does rho activation increase the amount of acetylated microtubules in cells? 
C3H10T½ fibroblast cells were then stained for immunofluorescence microscopy 
after undergoing one hour treatment with the rho inhibitor, one hour treatment with the 
ROCK inhibitor, two hour treatment with the rho activator, or did not undergo treatment. 
The staining of these cells was observed and then categorized into those with moderate 
acetylation, those with less/few acetylation, and those with increased/higher acetylation. 
After three experiments the data was quantified. These results show the same results as 
those seen with the western blot, with rho inhibited cells having less acetylation than the 
control, ROCK inhibited cells not differing from the control cells in acetylation, and rho 
activated cells having more acetylation than the control (Figure 8). The difference in 
percentage of cells with less/fewer acetylation between the control cells and those 
treated with the rho inhibitor was found significant (P=0.001) and as well as those cells 
with moderate amounts of acetylation (P=0.02). The decrease in the amount of 
acetylated microtubules when rho is inhibited was again seen significant. Furthermore, 
the difference in percentage of cells with increased/more acetylation between the control 
cells and those treated with the rho activator was found to be significant (P=0.008) and 
as well as those cells with less/fewer amounts of acetylation (P=0.0007). The increase in 
the amount of acetylated microtubules when rho is activated was therefore found 
significant. 
 
 
 
 
 
 
 
Figure 4: Immunofluorescence microscopy of the localization of actin stress fibers 
(green) and the paxillin, a protein within focal adhesions, (red) of cells were be observed. 
For both the one hour and four hour treatments, stress fibers were disrupted and paxillin 
was delocalized from adhesion plaques compared to the control. 
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A)  
B)
Figure 5: Cells stained with an antibody to alpha tubulin (green) and acetylated tubulin 
(red) treated with rho inhibitor for one hour, four hours, and those without treatment. A) 
Analysis of the percentage of cells showing fewer, moderate, and increased amounts of 
acetylation on their MTs.B) Percentages of the categories of cells with moderate (blue), 
fewer/less (red), and increased/more (green) for the control, one hour treatment, and 
four hour treatment. Means were gained over three experiments. 
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A)  
B)
Figure 6: Cells stained with an antibody for alpha tubulin (green) and detyrosinated 
tubulin (red) treated with rho inhibitor for one hour, four hours, and those without 
treatment. A) Analysis of the percentage of cells showing fewer, moderate, and 
increased amount of acetylation on their MTs. B) Percentages of the categories of cells 
with moderate (blue), fewer/less (red), and increased/more (green) for the control, one 
hour treatment, and four hour treatment. Statistics were gained over three experiments. 
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Table 1: Quantification of Protein Concentrations from Western Blot 
Figure 7: Imaged blot of lysates from cells treated with rho inhibitor for one hour, ROCK 
inhibitor for one hour, rho activator for 2 hours, or control cells. The ratio of acetylation to 
GAPDH was determined (Table 1). 
Protein Control Rho Inhibitor ROCK 
Inhibitor 
Rho Activator 
Ratio: 
Acetylated 
Tubulin/GAPDH 
0.18 0.11 
(40% 
Decrease) 
0.18 0.35 
(100% 
Increase) 
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 Figure 8: Graphical representation of cells that were either treated with a rho inhibitor for 
one hour, ROCK inhibitor for one hour, rho activator for two hours, or not treated. 
Immunofluorescence microscopy was used and cells were stained for total tubulin and 
acetylated tubulin. Cells were categorized into having moderate (Blue), fewer/less (Red), 
or more/increased (Green) amounts of acetylated tubulin. 
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Discussion: 
 We expected to see an increase in tubulin acetylation upon rho inhibition and 
found the opposite. Our expectation was based on the hypothesis that there is a 
reciprocal relationship between cell contractility and microtubule stability. Since MT 
depolymerization increases cell contractility (Danowski, 1989) via rho activation (Liu et 
al., 1998); we hypothesized that if a reciprocal relationship existed, a decrease in 
contractility would lead to more stable MTs. And stable MTS have been found to have 
more acetylation (Li et al., 2015) and detyrosination (reviewed by Westermann and 
Weber, 2003). One possible explanation for the increase in MT acetylation is that the rho 
inhibitor did not work properly, but analysis of f-actin in rho inhibited cells showed the 
characteristic loss of stress fibers as expected (Alberts et al., 2009).   
 There were no significant changes to the amount of detyrosination to 
microtubules when rho was inhibited. Detyrosination has been found to tag or occur to 
stable microtubules, and so we concluded that the inhibition of rho does not cause the 
stabilization of microtubules. This contrasts recent research where the inhibition of rho 
was found to increase the amount of detyrosination, and therefore microtubule stability, 
in NH-3T3 cells. The detyrosination was shown to be regulated by mDia2, and the 
upstream effector of mDia2 is rho (Palazzo et al., 2001). This research showed that rho 
is the upstream effector for other cell regulatory pathways as well for the activation of 
myosin-light chains. Our methodology for determining changes in MT detyrosination only 
looked at the localization of the detyrosination and not the total amount of detyrosinated 
MTs. Western blot analysis for detyrsoinated tubulin should have been done to confirm 
that in C3H10T½ cells no change to detyrosinated MTs occurred.  
 There was a change observed to the amount of microtubule acetylation when rho 
was inhibited, suggesting that a feedback mechanism exists. Acetylation has been seen 
to occur on microtubules in cells that have been put under stress and when treated with 
drugs to depolymerize the microtubules, nocodazole, the microtubules remain stable. 
There was a significant decrease observed in the amount of acetylated microtubules in 
cells with inhibited rho observed in both immunofluorescent microscopy and western 
blotting. We speculate that the decrease in acetylated microtubules is representative of 
an increase in microtubule dynamics and is reflective of the fact rho is an integrator of 
many signals and pathways, therefore making the output hard to predict. 
It has become increasingly clear that rho activation leads to a variety of 
downstream effectors, sometimes even seemingly opposite effects. For example 
research by Naranatt et al. (2004) and Destaing et al. (2004) shows contrasting results 
with each other and our results. The changes in acetylation to MTs when the contractility 
pathway has been altered have been studied in different cell lines with differing results. 
When the human Herpesvirus-8 (HHV-8) was introduced into human fibroblast cells, 
dermal microvascular endothelial cells, and embryonic kidney cells, hyperacetylation 
was observed. One of the many functions of this virus is its integrin interaction with 
ligands that control the cytoskeleton remodeling system, showing that a suggested 
manner in which virus works is rho dependent. Naranatt et al. (2004) found that rho 
inhibition of HHV-8 infected cells decreased acetylation tubulin. While Destaing et al. 
(2004) found an increase in tubulin acetylation in rho-inhibited osteoclasts. The cells 
were interestingly found with no differences in detyrosinated MTs, similar to our results 
but in contrast to Palazzo et al. (2001). Using exoenzyme C3 fused to the HIV TAT 
protein fragment to inhibit rho activity and then treating the osteoclasts with nocodazole, 
it was observed that cells treated with the rho inhibitor were able to resist nocodazole 
depolymerization for a significantly longer amount of time than the control cells. With the 
MTs proven to be stabilized, the amount of acetylation and detyrosination to tubulin was 
studied. Osteoclasts treated with the rho inhibitor had significantly more acetylated 
tubulin than the control cells, yet no difference in the amount of detyrosination was 
observed (Destaing et al., 2004). Therefore, it can be determined that this crosstalk of 
the response in regards to the action of acetylation enzymes must be finely tuned to 
specific cell types, most likely due to their function, and that there is no direct connection 
between rho and the acetylation of MTs. Rho is instead an integrator of many signals 
and pathways, and it is unknown what downstream pathway gets activated to acetylate 
MTs or effect other post-translational modifications.  
 Knowing that microtubule depolymerization activated rho (Liu et al., 1997), we 
investigated what would occur if rho was activated via a membrane permeant rho 
activator as opposed to activating rho by depolymerizing the microtubules. Rho 
activation led to an increase of microtubule acetylation that was observed through 
immunofluorescence microscopy and western blotting, showing the exact opposite of 
when rho is inhibited. This allowed us to speculate that this relationship between cell 
contractility and microtubule acetylation was reciprocal. This increase in acetylation to 
microtubules was due to either the decrease in the activity of HDAC6 or an increase in 
the activity of the enzymes that acetylate microtubules such as alpha-tubulin 
acetyltransferase. In increasing acetylation, we can speculate that the dynamics of the 
microtubules are decreasing, which would work to prevent microtubules from 
depolymerizing, which could be a method of preventing further activation of rho (Figure 
9). 
 Figure 9: Working model for the relationship between microtubules and cell contractility 
The downstream effector of this pathway, ROCK, was also investigated. So far 
the only changes in rho activity had been observed with the assumption that the 
changes to the amount of microtubule acetylation was because of the decrease or 
increases in cell contractility. Yet, what if this was instead due to an unknown 
downstream effector of rho (Figure 10)? Therefore, the inhibition of rho kinase, ROCK, 
was observed using both immunofluorescence microscopy and western blotting. 
Surprisingly there was no change in the amount of acetylation to microtubules observed 
through both immunofluorescence microscopy and western blotting, which led to the 
conclusion that rho is the only member of the rho pathway that is somehow able to 
regulate the acetylation to microtubules. Much like how rho was discovered to be the 
upstream effector to mDia2 activation to lead to an increase in detyrosination, rho must 
be the upstream effector in an undiscovered pathway that activates a regulator of 
acetylation to microtubules (Palazzo, A.F. et al., 2001). This pathway would allow for the 
increased activity of HDAC6 to decrease acetylation when rho is inhibited or the 
activation of enzymes that acetylate microtubules when rho is activated.  
 
Figure 10: Working model for possible downstream effectors of rho 
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